Validation of AI-ENDO System in Endoscopic Submucosal Dissection
Recruiting
N/A
Interventional Study
Superficial Esophageal, Gastric or Colorectal Lesions
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 85
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 60 (estimated)
- Sponsor
- Chinese University of Hong Kong · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study is a pilot trial designed to evaluate the feasibility and safety of Al-ENDO assisted ESD in patients with gastrointestinal superficial lesions. Patients with gastrointestinal superficial lesions are scheduled for conventional ESD will be screened for eligibility. The study consists of a few stages:
1. In the first phase, the Al-ENDO system will be tested in the background of the ESD pr…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patient with superficial esophageal, gastric or colorectal lesions, scheduled for endoscopic submucosal dissection (ESD).
* Age between 18 and 85.
Exclusion Criteria:
* Patient who refused to participate.
* Other cases deemed by the examining physician as unsuitable for safe…
Contacts